1 in 3 Americans Without Heart Disease May Have High Cholesterol Under New Guidelines, Study Finds

A new analysis found that nearly one-third of U.S. adults without heart disease have LDL cholesterol levels above the goals set by updated 2026 guidelines.

New LDL cholesterol guidelines personalize targets based on your overall cardiovascular risk.
One in three adults without heart disease may have LDL levels above new recommended targets.
Lifestyle changes, like eating more fiber and less saturated fat, can help lower LDL cholesterol naturally.

Heart disease is the leading cause of death in the United States, and high LDL cholesterol (or “bad” cholesterol) is one of the biggest and most modifiable risk factors of developing the condition.12

For years, doctors and patients alike have relied on cholesterol guidelines to determine when and how aggressively to treat elevated LDL levels. Now, a new set of guidelines and a recent study published in JAMA suggests millions of Americans may not realize how their cholesterol could be affecting their heart health.

Researchers from Mass General Brigham applied the newly released 2026 ACC/AHA Guideline on the Management of Dyslipidemia to a nationally representative sample of U.S. adults and found that roughly 1 in 3 adults without heart disease (and nearly 4 in 5 of those with established heart disease) have LDL cholesterol above the levels the updated guidelines recommend.

How Was This Study Conducted?

Researchers analyzed data from approximately 2,300 U.S. adults ages 30 to 79 from the National Health and Nutrition Examination Survey (NHANES) 2021-2023.3 Using LDL cholesterol measurements and information about existing cardiovascular conditions, medications and risk factors, the research team applied the LDL treatment goals outlined in the newly released 2026 ACC/AHA dyslipidemia guidelines to estimate how many Americans are currently above the new recommended targets and how many of those people aren’t receiving cholesterol-lowering treatment.

We should note that the NHANES data was collected before the 2026 guidelines were published, so these findings represent a snapshot of where the U.S. population stands relative to goals that many doctors haven’t yet formally adopted.

What Did This Study Find?

The study found significant gaps between where Americans’ LDL levels actually are and where the new guidelines say they should be, with the size of the gap varying based on cardiovascular risk.

Among adults without a prior heart attack, stroke or other cardiovascular event (called primary prevention), roughly 1 in 3 had LDL cholesterol levels above the recommended goal under the new guidelines. Of those, about 3 in 4 were not receiving any cholesterol-lowering medication.

Among those with established cardiovascular disease, nearly 4 in 5 people were above the new recommended LDL targets. Approximately 62% of those individuals were already receiving cholesterol-lowering therapy but had yet to reach the lower goals. The remaining 38% were on no treatment at all.3

Limitations

Because the study was a cross-sectional analysis of NHANES data, it captures a single snapshot in time and cannot track how people’s cholesterol or treatment status changes over the years. The data were also collected before the 2026 guidelines were published, meaning doctors hadn’t yet had the opportunity to apply the new targets in practice, so the treatment gaps identified here may narrow as guidelines are adopted.

Additionally, NHANES surveys a nationally representative sample but may not fully capture every subgroup of the U.S. population. The study’s cardiovascular risk classification relied on available survey data, which may not reflect each participant’s complete clinical picture.3

How Does This Apply to Real Life?

The most important takeaway from this study is that LDL targets are now more personalized than ever, and are tied specifically to your overall cardiovascular risk. Also, many people may be overdue for a conversation with their doctor about where they stand.

Here are a few things to consider discussing at your next doctor appointment:

Ask for your LDL number. Many people don’t know their actual LDL level. A simple blood test called a fasting lipid panel provides this information.
Ask what your target should be. Under the 2026 guidelines, your recommended LDL goal depends on your personal risk profile, which is now assessed using the updated PREVENT cardiovascular risk calculator. Your doctor can run this calculation and explain what it means for you.
Don’t assume treatment means medication. For many people at lower risk, lifestyle strategies like a diet low in saturated fat and rich in fiber, regular physical activity and not smoking remain the foundation of cholesterol management. Those strategies may be enough to reach a healthy cholesterol level without medication.
If you have existing heart disease, ask whether your current treatment is enough. For this group, the new guidelines set a stricter LDL target of below 70 mg/dL or even below 55. If you’re already on a statin but haven’t had your levels rechecked against the new targets, it may be worth revisiting.
Consider asking about a coronary artery calcium (CAC) scan. The 2026 guidelines recommend CAC scoring as a tool to help refine your risk assessment and guide treatment decisions, especially for those at borderline or intermediate risk.4

Read More : https://www.eatingwell.com/high-cholesterol-prevalence-new-study-12031502